verified SJR 1,07 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · Springer Publishing Company

workspace_premium Q2 — Endocrinology, Diabetes and Metabolism visibility_off Double blind peer review lock_open Open Access · DOAJ Unclaimed

Diabetes Therapy

Diabetes Therapy is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 59. It is an CC BY-NC Journal with a Double blind peer review review system, and It has a price of 3080 €. The scope of the journal is focused on diabetes, obesity, metabolic syndromes, type 1 diabetes, type 2 diabetes. It has an SJR impact factor of 1,07 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,07.

ISSN: 1869-6953

Editorial: Springer Publishing Company

Category: Endocrinology, Diabetes and Metabolism

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guía para Autores (Guidelines)

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,07 Q2

H-index 59

Tasa de Aceptación pie_chart

33%

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

6 semanas

Campo Average_time_publication_weeks

Coste de Publicación (APC) payments

3.080 € Open Access

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science DOAJ

SJR Impact

1,07

H-index

Docs (year)

168

Docs 3y

499

Total refs

6838

Cites 3y

1534

Citable 3y

465

Cites/Doc 2y

2.62

Ref/Doc

40.7

Immediate OA

3080 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiovascular Risk in Type 1 Diabetes Mellitus

Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons

Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L

Correction to: A Practical Guide to Delivering Nutritional Advice to People with Diabetes

Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study

Comparative Efficacy of Adding Sitagliptin to Metformin, Sulfonylurea or Dual Therapy: A Propensity Score-Weighted Cohort Study

Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus

Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study

Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study

SHOW MORE ARTICLES

Changing Patients' Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial

A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation

Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis

Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review

Association Between Maternal Glucose/Lipid Metabolism Parameters and Abnormal Newborn Birth Weight in Gestational Diabetes Complicated by Preeclampsia: A Retrospective Analysis of 248 Cases

Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'

Aspirin Versus Clopidogrel Monotherapy for the Secondary Prevention of Recurrent Cerebrovascular Attack Following Previous Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme

Adherence to Insulin, Emotional Distress, and Trust in Physician Among Patients with Diabetes: A Cross-Sectional Study

Accuracy Evaluation of CONTOUR¬ÆPLUS Compared With Four Blood Glucose Monitoring Systems

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus